<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 255 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page254.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=255">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 255 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 255</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=255"><img src="../thumb/255.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>218 / 2020-04                                                   Genital System - 17.1.1 / 17.1.2 / 17.1.3
                                                          st
   Dosage: 1 tab at same time dly, commenc. 1st day menstr.cycle.  Dosage: 1 tab.at same time dly.x28 consecut.days commenc.1  day   abnormal uterine bleeding; post-partum subinvolution of the uterus;
   Contraindications, Side effects, Special precautions, Drug   of menstr.bleed. Start subseq. pack immed.aft.finish.prev.pack irre-  past history of ectopic gestation; known or suspected malignancy of
   interactions: See sect.head note.  spect.of pres./absenc.of withdr.bleed.  reproductive organs; cervical dysplasia where definitive diagnosis
   VONEL Ranbaxy [P/S]          Contra indications, Side effects, Warnings and special pre-  and appropriate treatment have not been provided; proven allergy
                                cautions, & Drug interactions: See sect.headnote.
                                                              to copper and any disorder to copper metabolism (copper IUD’s only).
   Levonorgestrel                                             WARNINGS: If pregn.occurs in a patient with an IUD in situ there is an
   Indications: Prevent of pregn.within 72 hrs.of unprotect.sex.inter-  increased risk of spontaneous abortion & of septic abortion. Ectopic
   course/recognis.fail.of mechanic. methods.                 pregnancy & pelvic inflammatory diseases are more common in IUD
   (S2) TABS, 49/21.8.2/0574    17.1.2   Locally acting       users. Embedding & perforation of the uterus may occur.
   723165-001: 0,75 mg, 2, R55,04                             PRECAUTIONS: Patient should be counselled, a complete medical
   Dosage: 2 tabs.as sngl.admin.pref.within 12 hrs. but no later than 72   NUVARING, MSD [P/S]  history obtained and a physical examination performed before
   hrs.aft.unprotect.sex. intercourse. The earlier admin.the more effect.   Etonogestrel 11,7 mg, ethinylestradiol 2,7 mg   insertion. Anaemia or history of menorrhagia or hypermenorrhoea;
   Furth. unprotect.intercourse to be avoid.with only mechan/ chemic.  Indications: Contracept.  valvular or congenital heart disease; menopause; an allergic skin
   contracept.till next menstr.per.  (S3) VAG.RING. 38/34/0171.  reaction may develop with IUCD’s. Neurovascular reactions may
   Contraindications: Pregn./susp.pregn., undiagn. vag.bleed., hist. of/  715533-001: 1, R162,74  occur during insertion or removal.
   curr.high risk of arter.dis., sev. hepat.impairm., repeat.use as undesir.  Dosage: Insert & leave in place for 3 contin. wks. Remov.aft. 3 wks.
   hormon. stress & poss sev.cycles disturbs.poss.  of use on same day of wk.ring was insert. New ring to be insert.aft.
   Side effects: Anaphylax, anaphylact.reacts., disturb.bleed.pat-  ring-free interv.of 1 wk.  KYLEENA (MDR Listing)
   terns incl.spott., early or delay. mens., hyperglycaem., adren.insuf-  No hormon.contracept.use in preced.cycle: Insert on day   MIRENA (MDR Listing)
   fic., Cush.syndr. premenstr.syndr.-like sympts., alt.ser.lipid profiles,   1-5, but at latest on day 5 of cycle, even if menstr.bleed not finish.
   weight chang., drowsin., mood changes, nervousn., insomn., ment.  Chang.from combin.oral contracept.: Insert at latest on day   KYLEENA, Bayer [P/S] &
   depress., dizzin., headache, hypotens., thromboembol., GI disturbs.,   follow.tab.-free/placebo tab.interv. of prev.comb.oral contracept.  Levonorgestrel
   jaund., alter.LFT, skin rash, melasma, hot flush., hair loss, hirsut., acne,   Chang.from progestog.-only method/ progestog. -releas.IUS:   Indications: Contracept.up to 5 yrs. in women ≥ 18 yrs.
   urticar., bone min.density loss, osteoporos., osteoporot.fract., breast   Minipill: Switch on any day. Implant/IUS: Switch on day of remov.   (S4) IU DEL SYST, A47/32.9/0037
   tendern/-pain/-chang., ovar.enlargem., ovar.cyst format., galactorrh.,   Inject.: Switch on day next inject.due.  3000026-001: 19,5 mg, sngl with access., R3 139,35
   decr.libido, gynaecomast., fatig., oed., fluid retent., fev.  Follow.first-trimest.abort.: Start immed.without need.for addit.  Dosage: Insert.by healthcare profess.exper.& train.in IUS insert.
   Warnings and special precautions: Emerg.only & unsuit.for reg.  contracept.meas. If immed.switch undesirab., follow advic.giv.for “No   Handle using asept.techniq.
   contracept., reliabil.of contracept. taken x21 days great., high ectop.  hormon. contracept. used in preced.cycle”, using alt. contracpt.meas.  Insertion: Insert.into uterine cavity &lt; 7 days of onset of menstruat./
   pregn.risk,caref. evaluat.of pts.becom.pregn.for poss.ectop.pregn.,   Follow.deliv./2 .trimest.abort: Start dur.4  wk. aft. deliv./2 .  immed.aft.1st trimest. abortion. Ref.to prod.lit.for insert.instruct. Can
                                       nd
                                                    th
                                                           nd
   eff.on conceptus in event of fail.not known, not to be used for pregn.  trimest.abort.  be replac. with new syst.at any time dur.cycle
   diagnos./in miss.or incompl. abort., no protect against STD’s., consult   Deviats.from recomm.regim.& shift./delay. period: Refer to prod.lit.  Postpartum insert: Postpone insert.until uterus fully involut.& not
   healthcare prof.3 wks.aft.admin., known/suspect. breast malign/tu-  earlier than 6 wks.aft.deliv., if involut. substant.delay.consid.wait.
   mours, undiagn.urin.tract bleed., hepat.dis., ment.depress.hist., hy-  Contraindications: Pres./hist.of ven.thrombos. with/-out pulm.  until 12 wks postpart.
                                embol,pres./hist.of arter.thrombos. / prodrom of a thrombos., known
   pertens., card./ ren.impairm., asthma, epilep., migraine, condits. ag-  Removal: Remove no later than end of 5th yr., if pt. wish.to con-
   grav.by fluid retent., diab.mellit., unsafe in porphyr., lact.intol., excret.  predisposit.for ven./arter.thrombos.with/-out heredit.involvem. e.g.   tin.using same method a new syst. can be insert.immed.follow.
                                APC resist., antithrombin-III defic., prot. C defic., prot.S defic., hyper-
   in breast milk with breastfeed.poss.6 hrs.aft.admin.       remov.of origin.syst.
   Drug interactions: Metabol.enhanc./reduc.eff. with some meds.  homocysteinaem.& antiphospholip. antibod., hist.of migraine with   Contraindications: Pregn., ac./recurr.pelvic inflamm. dis., con-
                                foc. neurolog.sympts., diabet.mellit.with vasc. involvem., pres.of sev./
   incl.anticonvuls./rifampicin/ rifabut./griseofulv./ritonavir/St John’s   dits.assoc.with incr.risk of pelvic infects. incl.gonorrh. & other STIs,
   Wort, ciclospor.plasma conc.incr.  multip.risk fact.for ven./ arter. thrombos., pancreatit./hist.thereof if   ac.cervicit./ vaginit., postpart.endometrit./infect.abort.dur.past 3
                                assoc. with sev.hypertriglyceridaem., pres./hist.of hepat. dis.as long
   YASMIN, Bayer [P/S]          as liv.funct.val.have not return.to norm., pres./hist.of liv.tumours (be-  mnths., cervic.neoplasm, uter./cervic.malign., progestog.-depend.
                                                              tumours, postmenopaus.wom., ac. liv.dis./liv.tumour, abnorm.uter.
   21 Hormonal tabs: Drospirenone 3 mg, ethinylestradiol 0,03 mg   nign/malign.)., known/suspect.sex-steroid influenc.malign., undiagn.   bleed.of unknown aetiology, congenit./acquir.uter.anomal. incl.fi-
   & 7 inact.tabs.              vag.bleed.,known/suspect.pregn.  broids which would interfer with insert./ retent.of IU syst.
   Indications: Oral contracept.  Side effects: Vag.infect., cervicit., cystit, UTI, incr. appetit, depress.,   Side effects: Infreq./freq./prolong.bleed., amenorrh., spotting,
   (S3) TABS, 34/18.8/0494      decr.libid., mood alt., headache, migraine, dizzin., hypoaesthes., vis.   oligomenorrh., ovar.cyst, vulvovaginit., upper genit.tract infect., dys-
   700089-001: 28, R159,55      disturbs., hot flush., abdom.pain/distens., naus., diarrh., vomit., con-  menorrh., breast pain/discomf., device expuls., genit. discharge, uter.
   Dosage: 1 tab.at same time dly.commenc.1  day of menstr.cycle.  stip., acne, alopec., eczema, prurit., rash, urticar., back/extremit.pain,   perforat., depress.mood/ depress., headache, migraine, GI disords.,
                     st
   Contraindications, Side effects, Special precautions, Drug   musc. spasm., dysur., micturit.urg., pollakur., breast tendern., genit.  acne/ seborrh., alopec., hirsut, hypersens.incl.rash/ urticar./ angioed.,
   interactions: See sect. headnote.  prurit.fem., pelv.pain/discomf., dysmenorrh., vag.disch., amenorrh.,   morphologic.changes of endometr. & weak loc.foreign body react.,
   YASMIN PLUS, Bayer [P/S]     breast discomf./ enlargem./mass, cervic.polyp, coit. bleed., dyspare-  proced. pain/ bleed., may precipit.vasovag.react.incl.seiz. in epilept.
                                un., ectrop.of cerv., fibrocyst.breast dis., menorrhag., metrorrhag.,
   21 Hormonal tabs: Drospirenone 3 mg, ethinylestradiol 0,03 mg,   premenstr.syndr., uter. spasm, vaginal burn./odour/pain, vulvovag.   pts., streptococc.sepsis.
   levomefolate calcium 0,451 mg & 7 hormone free tabs.with lev-  discomf./ dryn., fatig., irritabil., malaise, oed., sensat. of foreig.bod.,   Warnings and special precautions: Inform.pt of benef.vs risk bef.
   omefolate calcium 0,451 mg   weight incr., BP incr., med. device discomf./expel./complic./break.  insert., conduct physic. examin. incl.pelvic examin./examin.of breast/
   Indications: Oral contracept.& improv.folate status in women   Special precautions: Incr.risk of arter.& ven. thrombot.& thrombo-  cervic.smear, re-examin.pt. 4-12 wks.aft.insert. & once a year there-
   seek.oral contracept.        embol.diseas./events, incr.risk of VTE, thrombos., incr.in freq./sever.  aft./ more freq.if indicat., excl.pregn.& STDs, genit.infects.to be suc-
   (S4) TABS, 45/18.8/0535      of migraine poss. reason for immed.discont., poss.incr.tumour risk.,   cessful.treat.prior to insert., fundal posit.imp. for max.effic.& reduc.
   723736-001: 28, R152,64      incr. risk of pancreatit.in women with hypertriglyceridaem./ fam.hist.  risk of expuls., caut./consid.remov.in focal migraine with asymmet-
   Dosage: 1 tab.at same time dly.x28 days commenc. 1  day of   thereof, susp.use of ring & treat if sustain.clinic.signif. hypertens. de-  ric.vis.loss/other sympts.indic.trans. cerebr. ischem./sev.headache/
                           st
   menstr.cycle.                velops, poss.deteriorat.of jaund./ prurit.relat.to cholestas/gallstone   jaund./mark.incr.in BP/ sev.arter.dis.incl.stroke & MI, congenit.heart
   Contraindications, side effects, special precautions, drug   format./ porphyr./SLE/ haemolyt. uraem.syndr./Sydenham’s chorea/   dis./ valvul.heart dis.at risk of infect.endocardit., monit.bld.gluc.conc.
   interactions: See sect. headnote.  herpes gestation./otoscleros.-relat.hear. loss/ angioed., ac/chron.dis-  diabet.as gluc.tol.poss.affect., infreq./incr.bleed./amenorrh., consid.
   YAZ, Bayer [P/S]             turb.of liv.funct.may necessit. discont.untill.markers of liv.funct. ret.   pregn.if menstruat. does not occur within 6 wks.of prev. onset, eval.
                                                              pt.fully for risk facts.assoc.with pelvic infect., bacteriolog.exam.&
   24 Hormonal tabs: Drospirenone 3 mg, ethinylestradiol 0,02 mg   to.norm. recurr.cholestat.jaund.&/prurit.relat.to cholestas. first occurr.  monitor.advis.with any sympts. indic.infect., remove in case of recurr.
   & 4 inact.tabs.              dur.pregn./prev.use of sex steroids necessit.discontinuat., poss.eff.of   endometrit./pelvic inflamm.dis/ac.infects that are sev./non-respons.
   Indications: Oral contracept., mod.acne vulgaris in women seek   periph. insul. resist& gluc.tol. in diab.wom., Chrohn’s dis./ ulcerat. co-  to treatm., expuls./part.expuls., perforat./penetrat.of uterine corpus/
   oral contracept., premenstr. dysphoric disord.(effic.not assess.  lit. have been assoc.with hormon. contracept., women with tendenc.  cervix, incr. ectopic pregn.risk, excl.pregn.if remov.threads not vis.on
   beond 3 cycles) where OC choosen as method of birth control. Not   to chloasma should avoid expos.to sun/UV radiat., diffic.insert. may   follow-up examin., incr.perforat.risk assoc. with insert.while breast-
   eval.for treatm.of PMS.      be exper.in pts.with uterin.cerv.prolaps., cystocele &/rectocele, sev/  feed.& for upto 36 wks.aft. giv.birth, ovar.cysts/enlarg.ovar.follicl.,
   (S4) TABS, 41/21.8.2/0842    chron.constip., consid. incorr. posit.of. ring in case of cystit.sympts.,   remove if pregn.occ.& excl.ectop.pregn., safety & effic.not eval.
   712856-001: 28, R192,90      period. med.assess.advis.with spec.ref.to BP/ breasts/ abdom.& pelv.  in pts &lt;18 yrs/ren.impairm., not for use as post-coital contracept.
                           st
   Dosage: 1 tab.at same time dly.x28 days commenc. 1  day of   orgs.incl.routin.cervic. cytolog., does not prot.against HIV infects. &   Interactions: Incr.clear.of levonorgestrel with phenytoin/ barbitu-
   menstr.cycle.                other STDs., non-compl./concom.meds.reduc.effic., use barrier meth.  rates/primidone/ carbamazepine/ rifampicin/oxcarbazepine/ topira-
   Contraindications, Side effects, Special precautions, Drug   dur.treatm.with hepat.microsom. enzym.-induc.meds.& concom.an-  mate/ felbamate/griseofulvin/St. John’s wort., incr./decr.levonorg-
   interactions: See sect. headnote.  tibiot.& 28 days aft. discont. hepat.microsom.enzym.-induc.meds/7
                                days aft.discont.antibiot.,if concom.med.admin. runs beyond 3 wks.   estrel plasma conc. with HIV/HIC protease inhibits./non-nucleoside
   YAZ PLUS, Bayer [P/S &       of ring-cycl.next ring should be insert. immed.without usual ring-  reverse transcript.inhibits.
   24 Hormonal tabs: Drospirenone 3 mg, ethinylestradiol 0,02 mg,   free interv., excl. malign./ pregn.if bleed.irreg.occ.aft.prev.reg.cycl.   See also MDR page 233.
   levomefolate calcium 0,451 mg & 4 hormone free tabs.with lev-  while dev.used accord.to recomm.regim., lab.test results poss.alt.   MIRENA, Bayer [P/S] &
   omefolate calcium 0,451 mg   incl.biochem.param.of liv/thyr./ adren./ ren.funct., plasma lev.of carr.  Levonorgestrel.
   Indications: Oral contracept.& improv.folate status in women seek.  prots., lipid/ lipoprot. fracts., param.of carbohydr.metabol., param. of   Indications: Contracept., idiopath.menorrhag., endometrial hyper-
   oral contracept, mod.acne vulgaris in women seek oral contracept.,   coagulat./fibrinolys.  plas.protect.dur.oestrog. replacem. ther.
   premenstr. dysphoric disord.(effic.not asses beyond 3 cycles) where   Drug interactions:. Meds.induc.microsom. enzym. can incr.sex   (S4) IU SYST. A32/34/0332.
   OC choosen as method of birth control. Not eval.for treatm.of PMS.  horm.clear, poss.contracept. fail. with antibiot., poss.interfer.on   20 µg/24 hrs.(52 mg/syst.).
   (S4) TABS, 45/21.8.2/0534    metab.of other meds. e.g. cyclospor.tiss.& plasma conc.incr. /lamo-  852252-005: 1 Pack, R3 139,37
   723730-001: 28, R184,60      trigine tiss./plasma conc.decr. Ref.to prescrib. info of concom.meds.  Dosage: . Effect.for 5 yrs. Insert 1 unit into the uterine cavity within
   Dosage: 1 tab.at same time dly.x28 days commenc. 1  day of   to identify poss. interacts.
                           st
   menstr.cycle.                                              7 days of menstruat.onset./ immed.aft.1 st  trimest.abort./6 wks.post-
                                                              part. May be replaced at any time of cycle/when remov.old syst.
   Contraindications, side effects, special precautions, drug
   interactions: See sect. headnote.                          For endometr.protect.dur.oestrog.replacem.ther. insert any time in
   See also MDR page 242.       17.1.3   Contraceptive devices  amenorrh.woman/dur.last days of menstruat/withdr.bleed. Do not re-
                                                              move aft.day 5 of menstr.cycle in sexual.act.wom.unless pregn.desir.
   ZOELY 2,5/1,5 mg, MSD [P/S]  CONTRA-INDICATIONS: Confirmed or suspected pregnancy;   Contraindications: Known/suspect.pregn., low. genit. tract infects.,
   24 hormon.tabs: Nomegestrol acetate 2,5 mg, estradiol hemihydr.1,5   congenital or acquired distortions of uterine cavity or cervical canal;   PIDs, postpartum endometrit., infect.abort.over past 3 mnths., cer-
   mg & 4 inact.tabs            pathology of endometrium or myometrium associated with menstrual   vicit., cervic. dysplas., uter./cervic.malign., undiagn.abnorm. uter.
   Indications: Oral contraception  disorders; uterine depth less than 6 cm or greater than 9 cm; acute   bleed., progestog.-depend.tumours, congenit./ acquir. uter.anomaly
   (S3) TABS, 45/18.8/0064      or subacute pelvic inflammatory disease or past history of recurrent   incl.fibroids if they distort uter.cavity, condits.assoc.with incr.infect.
   720904-001: 28, R157,46      pelvic inflammatory disease; acute or chronic cervicitis; undiagnosed   suscept., ac.liv.dis./tumour, not post-coit. contracept.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page254.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>&nbsp;&nbsp;&nbsp;<a href="page255.html">255</a>&nbsp;&nbsp;&nbsp;<a href="page256.html">256</a>&nbsp;&nbsp;&nbsp;<a href="page257.html">257</a>&nbsp;&nbsp;&nbsp;<a href="page258.html">258</a>&nbsp;&nbsp;&nbsp;<a href="page259.html">259</a>&nbsp;&nbsp;&nbsp;<a href="page260.html">260</a>
             </td>
             <td width="35%"><a href="page256.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page256.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
